OptumRx Mounjaro Prior Authorization: Requirements, Denials, and Approval Checklist (2026)
The exact diabetes proof OptumRx needs, the auto-approval rule nobody else explains, and a lane-by-lane map so you don’t spend weeks on the wrong appeal.
Which OptumRx Mounjaro “lane” are you in?
OptumRx doesn’t treat every Mounjaro request the same way. The outcome rides almost entirely on your diagnosis and your plan’s rules. Find your row, then jump to the section it points to.
| Your situation | Is Mounjaro the right request? | What the file usually needs | Your best next move |
|---|---|---|---|
| Type 2 diabetes + recent labs | Usually yes (if your plan covers Mounjaro) | Chart notes plus one diabetes lab: A1C ≥ 6.5%, fasting glucose ≥ 126 mg/dL, OGTT ≥ 200 mg/dL, or random glucose ≥ 200 mg/dL with symptoms | Have your doctor submit a complete request electronically with the labs and dates |
| Type 2 diabetes diagnosed 2+ years ago | Usually yes | Chart notes confirming the diagnosis and ongoing treatment | If denied for "missing info," resend with chart notes |
| Want Mounjaro for weight loss, no diabetes | Usually NO -- wrong lane | (Mounjaro isn't approved for weight loss) | Ask about Zepbound or Wegovy instead |
| Obesity + sleep apnea | Usually ask about Zepbound, not Mounjaro | Weight-loss policy criteria | Ask your clinician if Zepbound fits and is covered |
| Got a "missing information" denial | Often a quick fix | The exact item the letter says is missing | Resend or appeal with that one thing attached |
| Your plan excludes weight-loss drugs | Appeal is low-yield without a covered diagnosis | Denial letter wording + plan benefit language | Confirm the exclusion; check covered options or the savings card |
| No doctor who handles this | The drug may fit, but the process stalls | A prescriber has to submit the request | Consider an insurance-aware telehealth visit |
Source basis: UnitedHealthcare’s commercial diabetes GLP-1 policy (Program 2025 P 1332-7), UnitedHealthcare’s separate weight-loss policy, OptumRx’s prior authorization process, and public appeal records.
Does OptumRx cover Mounjaro, and is prior authorization required?
OptumRx can cover Mounjaro, but almost always after a prior authorization — and whether it’s covered depends on your diagnosis and your specific plan. For UnitedHealthcare plans, the OptumRx policy lists Mounjaro as a diabetes drug and ties approval to proof of type 2 diabetes. Being “on the formulary” is not a promise of coverage.
Check your own plan in two minutes
Log in at optumrx.com, open the drug pricing and information tool, type “Mounjaro” and your dose, and look for the coverage alert. If it flags prior authorization, that’s your signal. You can also check a request’s status under Benefits and claims → Prior authorization or exception request. OptumRx says electronic requests are sometimes approved within minutes once your doctor submits them.
What are the OptumRx Mounjaro prior authorization requirements?
Here’s exactly what the policy accepts as proof of type 2 diabetes:
| Proof of diabetes | What the policy accepts | What to gather |
|---|---|---|
| A1C (3-month blood-sugar average) | 6.5% or higher | Lab report with the date |
| Fasting plasma glucose (after not eating) | 126 mg/dL or higher | Lab report noting fasting + date |
| 2-hour OGTT (glucose tolerance test) | 200 mg/dL or higher | The test report |
| Random plasma glucose | 200 mg/dL or higher with classic symptoms or a hyperglycemic crisis | Lab report plus a chart note describing the symptoms |
| Ongoing treatment (diagnosed 2+ years ago) | Chart notes confirming the diagnosis | Records showing you're being treated for type 2 diabetes |
Those thresholds mirror the American Diabetes Association’s 2025 Standards of Care, which the policy cites. Meet one of them in your records and you’ve cleared the core requirement.
Good news: no step therapy on this policy
About diagnosis codes (ICD-10)
Prior authorization forms usually ask for an ICD-10 code. Eli Lilly’s own Mounjaro paperwork guide gives common type 2 diabetes examples like E11.65, E11.8, and E11.9. But Lilly is clear, and so are we: a code alone won’t win approval if your chart doesn’t back it up. If you don’t actually have type 2 diabetes, attaching a diabetes code is a compliance problem — and the request can still be denied.
Give one point each for:
| +1 Diagnosis written out | +1 ICD-10 code included | +1 Chart note confirming type 2 diabetes | +1 Qualifying lab with date |
| +1 Treatment history | +1 Current medication list | +1 Denial letter (if resubmitting) |
The exact documents to hand your prescriber so the request goes in complete
Is there an OptumRx Mounjaro prior authorization form, and what number do I call?
In almost every case your prescriber — not you — submits the prior authorization, ideally through OptumRx’s electronic system. OptumRx asks providers to use electronic prior authorization (ePA) when possible. Knowing who does what saves you days.
| Who | What to do | Contact / where |
|---|---|---|
| Your prescriber | Submits the PA electronically (ePA) or by fax using OptumRx's PA request form | Call OptumRx PA line: 1-800-711-4555 |
| You (member) | Check status, gather records, call with questions | Number on your insurance card; or optumrx.com → Benefits and claims → Prior authorization or exception request |
| Medicare drug plan members | Separate OptumRx numbers apply | Use the number on your Medicare plan card |
Can OptumRx approve Mounjaro for weight loss, prediabetes, PCOS, or sleep apnea?
Usually not — and this is the single biggest reason Mounjaro requests get denied. Mounjaro is FDA-approved as an adjunct to diet and exercise to improve blood sugar in adults and children 10+ with type 2 diabetes. It is not approved for weight loss, and UnitedHealthcare’s policy states that drugs used for weight loss are typically excluded.
The pattern is simple: match the request to the medication that’s approved for your reason, and your odds change dramatically.
| If your real reason is… | Why a Mounjaro request gets denied | The lane to ask about instead | What to say to your clinician |
|---|---|---|---|
| Weight loss, no diabetes | Mounjaro isn't approved for weight loss | Zepbound (the tirzepatide approved for weight management) or Wegovy | "Does my plan cover Zepbound or Wegovy, and what do they require?" |
| Prediabetes | Prediabetes doesn't meet the type 2 diabetes bar | Weight-management coverage if you qualify | "Do I qualify for a covered weight-management option?" |
| PCOS | PCOS alone doesn't create a Mounjaro coverage lane | Depends on your other diagnoses and plan | "What's actually covered for my situation?" |
| Obesity + sleep apnea | Mounjaro isn't the sleep-apnea lane | Zepbound (UHC's weight-loss policy covers Zepbound for moderate-to-severe obstructive sleep apnea) | "Is Zepbound the right request for my sleep apnea?" |
| Heart disease + overweight | Mounjaro isn't the cardiovascular lane | Wegovy (covered for certain heart-risk uses when criteria are met) | "Would Wegovy fit my heart-risk diagnosis?" |
Not sure if this should be Mounjaro, Zepbound, or Wegovy?
If you’ve realized Mounjaro may be the wrong lane and want a free coverage report for Wegovy, Zepbound, or Ozempic, Ro’s free GLP-1 Insurance Coverage Checker contacts your insurer and tells you whether a medication is covered and whether it needs prior authorization. Ro does not offer Mounjaro and its insurance help is for the FDA-approved weight-loss medications it supports.
Check Zepbound / Wegovy coverage with Ro → free (sponsored affiliate link, opens in a new tab)Sponsored. For Zepbound/Wegovy/Ozempic weight-loss path. Ro does not offer Mounjaro.
What your doctor should send so OptumRx doesn’t deny it for “missing information”
The most common fixable denial is “missing information,” and the fix is a complete packet. A complete, accurate first submission is the single biggest thing that speeds up approval. You can’t write the clinical request yourself, but you can make it easy for your doctor’s office to get it right the first time.
The PA-ready packet (hand this list to your doctor’s office)
Plan and prescription details
- Your name and date of birth
- Plan name and member ID
- Drug, dose, quantity, and days' supply
- Diagnosis and ICD-10 code
Clinical proof
- A chart note confirming type 2 diabetes
- A1C lab report and date (and fasting glucose, OGTT, or random glucose if used)
- Treatment history -- what you've tried, and any side effects
- Current medication list and other conditions
If you’re resubmitting or appealing
- The denial letter (names the exact reason, the fix, and the deadline)
A short message you can send your prescriber
Three things not to do
How long does OptumRx Mounjaro prior authorization take?
Once your doctor submits a complete request, OptumRx says it usually takes up to 24 hours to process, and electronic requests are sometimes approved within minutes. The catch is that “submitted complete” part. OptumRx has also automated some prior authorizations for participating health systems — in-scope cases can be approved in roughly 30 seconds at the doctor’s office.
| Stage | Typical timing | What slows it down |
|---|---|---|
| Pharmacy flags PA required | Same day | Wrong dose, wrong plan, inactive coverage |
| Doctor submits the request (ePA) | Same day to a few days | Office backlog, missing labs |
| OptumRx reviews it | Often up to 24 hours after receiving it | Extra review, missing information |
| Automated in-scope approval | Seconds, at the office | Only for participating systems / eligible cases |
| Denial letter arrives (if denied) | After the decision | Mail or portal delay |
| Appeal or resubmission | Varies | Benefit exclusion, incomplete packet |
Why OptumRx denies Mounjaro — and the exact fix for each reason
Your denial letter is the map, and almost every Mounjaro denial falls into one of six buckets. The most common one — “missing information” — is usually a quick fix. The others each have a clear next move.
We read public appeal and external-review decisions — Massachusetts MassHealth appeals and a Michigan DIFS case involving OptumRx — to see how Mounjaro denials actually play out.
| What the letter says | What it usually means | Your best move |
|---|---|---|
| "Not FDA-approved for the requested use" / obesity or prediabetes | Requested for weight loss, which Mounjaro isn't approved for | If you have diabetes: resend with diagnosis + labs. If not: ask about Zepbound/Wegovy |
| "Insufficient clinical information" / "medical necessity not established" | Most common and most fixable denial -- the plan didn't get enough proof | Resend with diagnosis, labs with dates, and treatment history |
| "Step therapy / preferred alternative not tried" | Your plan wants a tried-first drug documented (not required on UHC's current commercial policy) | Document the trial with dates, or document why you can't take it |
| "Type 1 diabetes diagnosis" | Mounjaro is for type 2, not type 1 | Confirm the correct diagnosis; if your record shows type 2, make sure that's the diagnosis on the request |
| "Excluded under your plan" / weight-loss exclusion | Your plan chose to exclude this class -- the hardest denial | A clinical appeal rarely beats an exclusion; ask about a benefit exception, the savings card, or cash-pay |
| "Quantity limit" | A dose or supply limit was hit | Match the plan's quantity rules or have your doctor justify an exception |
The public decisions we reviewed
| Record | Drug + stated reason | Outcome | The lesson |
|---|---|---|---|
| Michigan DIFS (external review), involving OptumRx — 2023 | Mounjaro for obesity + prediabetes (BMI ~44, prior Wegovy) | Denial upheld | Mounjaro for obesity without type 2 diabetes gets denied -- not FDA-approved for that |
| Massachusetts MassHealth appeal — 2023 | Mounjaro for type 1 diabetes; "insufficient information" | Denied; resubmittable with records | Thin documentation is fixable -- if a covered diagnosis is there to prove |
| Massachusetts MassHealth appeal — 2023 | Mounjaro for obesity; drug excluded for weight loss | Denial upheld | A benefit exclusion is the hardest wall; clinical appeals rarely move it |
| Massachusetts MassHealth appeal — 2023 | Mounjaro; primary diagnosis listed as obesity | Denied; advised to pursue diabetes path if applicable | The request has to match a covered diagnosis, documented clearly |
When an appeal is worth it
- The letter says "missing information" and you have that information
- The plan misread or missed your diagnosis
- Your labs clearly qualify
- The drug is covered but the rules were applied wrong
- Your plan allows exceptions and your clinician will support one
When an appeal usually wastes time
- Your plan flatly excludes weight-loss drugs
- You're asking for Mounjaro for weight loss with no type 2 diabetes
- The diagnosis code doesn't match your medical record
- Your prescriber won't support the request
Appeal, resubmit, or switch? A simple decision tree
Resubmit when the file was incomplete. Appeal when your proof meets the rules but you were denied anyway. Switch the request when you’re in the wrong lane. Picking the right move first saves you the most time.
Start here:
- Is type 2 diabetes documented in your chart? Yes → check whether labs and chart notes were actually submitted. If not, resubmit. No → go to the weight-loss lane (Zepbound or Wegovy).
- Does the denial say “missing information”? Yes → resubmit with the exact missing item. No → read the precise denial reason before doing anything.
- Does your plan exclude weight-loss drugs? Yes → appeal is usually low-yield; ask your employer/plan about exceptions or compare cash-pay. No or unsure → check Zepbound/Wegovy criteria.
How to actually file an OptumRx appeal
Start with your denial letter — it is the source of truth. It names the reason, your deadline, the appeal level, and exactly where to send the request. Follow your letter, not a generic address found online.
- Mind the deadline. For commercial plans, the window to file an internal appeal is commonly around 180 days from the denial -- but your letter states your exact deadline.
- Ask for a peer-to-peer review. A phone call between your prescriber and the plan's reviewing doctor is often the fastest way to turn a denial around.
- File the written appeal using the address, fax, and instructions on your letter.
- Ask for an expedited appeal if waiting could harm your health -- those are usually decided within about 72 hours.
- Escalate to external review. If internal appeals fail, you can request an independent external review through your state's insurance regulator.
Mounjaro vs. Zepbound vs. Wegovy under OptumRx: which request fits you?
Mounjaro is the type 2 diabetes lane. Zepbound and Wegovy are the weight-loss (and related-condition) lanes when your plan covers them. Choosing the request that matches your diagnosis is the difference between a smooth approval and a frustrating denial.
| Medication | Cleaner approval lane | Reach for it when |
|---|---|---|
| Mounjaro (tirzepatide) | Type 2 diabetes | Your records support type 2 diabetes and your plan covers it |
| Zepbound (tirzepatide) | Weight management; moderate-to-severe sleep apnea where covered | You're chasing Mounjaro for obesity or sleep apnea |
| Wegovy (semaglutide) | Weight management; certain heart-risk and liver (MASH) uses where covered | Your denial is weight-loss or heart-related, not diabetes |
| Ozempic (semaglutide) | Type 2 diabetes | You have diabetes -- it's not a weight-loss workaround |
What Mounjaro costs with OptumRx — and the savings-card math
Once approved, your Mounjaro cost depends on your plan’s tier and deductible. Eli Lilly lists Mounjaro at $1,112.16 per fill at retail. With commercial insurance, Lilly’s savings card can drop eligible patients to as little as $25 per fill. The card can’t be used with government plans, and it expires December 31, 2026.
| Your situation | What the Lilly Mounjaro Savings Card does | The fine print |
|---|---|---|
| Commercial insurance that covers Mounjaro | Pay as little as $25 for a 1-, 2-, or 3-month fill | Max savings $150/month, up to $1,950 per year |
| Commercial insurance that does NOT cover Mounjaro | Pay as low as $499 for a 1-month fill | Up to $8,411 per year |
| Medicare, Medicaid, TRICARE, VA, or other government plan | Not eligible -- federal rules exclude these | No workaround |
The card can be used for up to 13 fills per calendar year; you must be 18+ and a U.S. or Puerto Rico resident; the prescription has to be for Mounjaro’s approved use (type 2 diabetes). Also ask your plan whether a 90-day fill or Optum home delivery changes your copay — OptumRx says home delivery may save money.
See the full Mounjaro savings card guide →
Special situations: Medicare, CHAMPVA, Medicaid, self-funded plans, type 1 diabetes, and renewals
A few situations change the playbook. Medicare and Medicaid have their own limits, government plans can’t use the savings card, and type 1 diabetes is outside Mounjaro’s approval.
| Plan type | Mounjaro for diabetes | Mounjaro for weight loss | Lilly savings card? | First thing to verify |
|---|---|---|---|---|
| UnitedHealthcare commercial | Covered with PA + diabetes proof | Typically excluded | Yes (if commercial) | Your plan's PA criteria + tier |
| Other OptumRx commercial / employer | Usually covered with PA | Often excluded | Yes (if commercial) | Whether your plan uses different criteria |
| Medicare Part D | Covered for diabetes with PA | Not for weight loss (federal rule) | No (government plan) | Your plan's formulary + tier |
| CHAMPVA | Covered for type 2 diabetes | Not for weight loss | No (government plan) | The CHAMPVA covered-use list |
| Medicaid | Usually covered for diabetes with PA | Rarely covered | No (government plan) | Your state's PA rules |
| Self-funded employer | Often covered for diabetes | May exclude the whole class | Yes (if commercial) | Whether weight-loss drugs are excluded |
If you need help: insurance-aware telehealth (and when to stay local)
A prior authorization needs a prescriber’s support — you can gather records, but the clinical request has to come from a doctor. If your current prescriber doesn’t handle GLP-1 paperwork, an insurance-aware telehealth program can check your coverage and submit it. Just know: no provider can guarantee OptumRx approval.
| Help path | Best for | Handles Mounjaro? | Submits the PA? | Cost |
|---|---|---|---|---|
| Your own doctor + plan | Anyone with type 2 diabetes | Yes | Yes (your prescriber) | Your copay (free help) |
| Lilly savings card / cash | Commercially insured, or paying cash | Yes (you still need a prescriber) | No | $25–$499+/fill depending on coverage |
| Sesame (telehealth visit) | Wanting a provider visit and a Mounjaro-specific conversation | Yes, if clinically appropriate | Provider can assist | ~$1,080–$1,300/mo cash for the medication |
| Ro (weight-loss program) | The weight-loss reader exploring Wegovy/Zepbound | No (Ro doesn't offer Mounjaro) | Yes, for the meds Ro supports | Membership $39 first month, then as low as $74/mo |
| Your employer / plan sponsor | Fighting a benefit exclusion | N/A | No | Free -- ask about exceptions |
Sesame — for a provider visit and a Mounjaro-specific conversation
Sesame lets you book a provider visit, and its Mounjaro page says a Sesame provider can assist with prior authorization paperwork if clinically appropriate. Sesame lists Mounjaro pens at about $1,080–$1,300 per month without insurance. Best if you want a provider visit and a Mounjaro-specific conversation.
See Sesame’s Mounjaro visit options →Sponsored. Best for a provider visit + PA help if clinically appropriate.
Ro — a free coverage check before you pick a weight-loss path
Ro offers a free GLP-1 Insurance Coverage Checker that runs your insurance and tells you whether a medication is covered and whether it needs prior authorization. For the FDA-approved weight-loss medications Ro supports — currently Wegovy pen, Zepbound autoinjector pen, and Ozempic — Ro’s insurance concierge submits the prior authorization and handles denials. Membership is $39 for the first month, then as low as $74/month with annual prepay; medication billed separately. Ro is a weight-loss program and does not offer Mounjaro itself.
Check FDA-approved GLP-1 coverage with Ro → free (sponsored affiliate link, opens in a new tab)Sponsored. Best if Mounjaro may be the wrong lane and you want a free coverage report for Wegovy, Zepbound, or Ozempic.
Safety: insurance approval is not medical clearance
Before you chase approval, it’s worth asking your clinician about:
How we verified this guide
We built this from official sources first, then checked it against real cases and provider pages. We can’t see your specific plan, so anything plan-specific is something to confirm in your own portal and denial letter.
| What we verified | Source | Status |
|---|---|---|
| Mounjaro is FDA-approved for type 2 diabetes (adults + children 10+) | FDA Mounjaro label | Verified |
| UnitedHealthcare commercial diabetes GLP-1 policy lists Mounjaro | UHC Program 2025 P 1332-7 | Verified |
| The exact diabetes lab thresholds + 12-month approval | Same policy | Verified |
| Step therapy removed (April 2024) | Same policy's change log | Verified |
| Weight-loss use typically excluded | Same policy | Verified |
| Zepbound/Wegovy on the weight-loss policy; Zepbound sleep-apnea path | UHC weight-loss policy | Verified |
| OptumRx processing time, ePA, prescriber line, status steps | OptumRx pages | Verified |
| Real Mounjaro denial/appeal outcomes | Massachusetts MassHealth + Michigan DIFS records | Verified (public) |
| Lilly savings-card terms + list price ($1,112.16/fill) | Eli Lilly official pages | Verified |
| Medicare GLP-1 Bridge drugs, dates, and diabetes carve-out | CMS Medicare GLP-1 Bridge page | Verified |
OptumRx Mounjaro prior authorization FAQ
Quick answers to the follow-up questions that send people back to search — coverage, criteria, forms, denials, timing, savings, renewals, and Medicare.
- Does OptumRx cover Mounjaro?
- Sometimes -- it depends on your plan and your diagnosis. UnitedHealthcare's commercial diabetes GLP-1 policy lists Mounjaro and approves it with proof of type 2 diabetes. Weight-loss use is usually excluded.
- Does OptumRx require prior authorization for Mounjaro?
- On nearly all plans, yes. Check the optumrx.com drug pricing tool or your pharmacy's alert, which flags if prior authorization is required.
- What labs does OptumRx need for Mounjaro?
- UnitedHealthcare's commercial policy accepts an A1C of 6.5% or higher, fasting glucose of 126 mg/dL or higher, a 2-hour glucose tolerance test of 200 mg/dL or higher, or a random glucose of 200 mg/dL or higher with symptoms as evidence supporting a type 2 diabetes diagnosis. Your clinician makes and documents the diagnosis.
- Can Mounjaro be approved without type 2 diabetes?
- It is much harder and usually the wrong request. Mounjaro is not FDA-approved for weight loss, and weight-loss use is typically excluded. If weight loss is the goal, ask about Zepbound or Wegovy.
- Does OptumRx require step therapy for Mounjaro?
- Not on UnitedHealthcare's current commercial diabetes GLP-1 policy -- that language was removed in April 2024. Individual plans may still add their own rules.
- Is there an OptumRx Mounjaro prior authorization form?
- There is no patient-facing form you fill out yourself. Your prescriber submits the request electronically (ePA) or by fax using OptumRx's PA request form. A prescriber can call OptumRx at 1-800-711-4555 for prior authorization or exception requests.
- What OptumRx phone number should I call for Mounjaro prior authorization?
- Members should start with the number on their insurance card, which routes to their plan. Prescribers can call 1-800-711-4555. Medicare drug-plan members have separate OptumRx numbers.
- How long does OptumRx Mounjaro prior authorization take?
- OptumRx says it usually takes up to 24 hours after a complete request is received, and electronic requests are sometimes approved within minutes. Missing information or appeals can take longer.
- Why did OptumRx deny my Mounjaro request?
- Most denials are for a weight-loss (off-label) request, missing clinical information, a plan exclusion, a wrong or miscoded diagnosis, or a quantity limit. The denial letter names the reason, which tells you the fix.
- Where do I check my OptumRx prior authorization status?
- Sign in at optumrx.com and go to Benefits and claims, then Prior authorization or exception request.
- How long is a Mounjaro approval good for?
- On the UnitedHealthcare commercial policy, authorizations are issued for 12 months.
- Does Medicare cover Mounjaro?
- Medicare can cover Mounjaro for type 2 diabetes but not for weight loss. The Medicare GLP-1 Bridge ($50/month, July 2026 to December 2027) covers weight-management drugs like Foundayo, Wegovy, and the Zepbound KwikPen, not Mounjaro.
- What is the cash price for Mounjaro if I'm denied?
- Eli Lilly lists Mounjaro at $1,112.16 per fill, though your real cost depends on pharmacy pricing, the savings card, and eligibility.
Still not sure which GLP-1 program is right for you?
Take our free 60-second matching quiz. Answer a few questions and get a personalized action plan for your exact situation — no charge.
Get my free action plan →Weight-loss goal? Check Zepbound/Wegovy coverage with Ro → free (sponsored affiliate link, opens in a new tab)Related guides
- → UnitedHealthcare Mounjaro prior authorization
- → GLP-1 providers that accept OptumRx
- → Mounjaro Savings Card 2026: $25 or $499?
- → Blue Cross Mounjaro prior authorization
- → Express Scripts Mounjaro prior authorization
- → CVS Caremark Mounjaro prior authorization
- → GLP-1 formulary tier explained: 2026 cost decoder
- → Does UnitedHealthcare cover Wegovy?
- → Free 60-second GLP-1 matching quiz
Sources
- U.S. Food & Drug Administration -- Mounjaro (tirzepatide) Prescribing Information (label); DailyMed (NLM) Mounjaro label
- UnitedHealthcare -- Clinical Pharmacy Program, Prior Authorization/Notification: Diabetes Medications -- GLP-1 & Dual GIP/GLP-1 Receptor Agonists (Program 2025 P 1332-7, effective 7/1/2025)
- UnitedHealthcare -- Prior Authorization/Notification: Weight Loss / Appetite Suppression Medications (commercial)
- OptumRx -- prior authorization process, contact, and member FAQ pages; UnitedHealth Group -- automated prior authorization announcement
- Eli Lilly -- Mounjaro Savings Card terms and list-price page; Mounjaro prior authorization guide
- CMS -- Medicare GLP-1 Bridge, Information for Medicare Beneficiaries; Medicare & You handbook (2026 Part D out-of-pocket cap)
- Commonwealth of Massachusetts, Board of Hearings -- Mounjaro prior authorization appeal decisions (public records)
- State of Michigan, Department of Insurance and Financial Services (DIFS) -- OptumRx Mounjaro external-review decision (public record)
- U.S. Department of Veterans Affairs -- CHAMPVA covered medications
- KFF -- Medicaid coverage of and spending on GLP-1s
- Ro -- GLP-1 Insurance Coverage Checker, pricing, and weight-loss insurance pages
- Sesame -- Mounjaro provider page